Hartford Funds Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-8,060
Closed -$866K 96
2025
Q2
$866K Buy
8,060
+101
+1% +$10.2K 0.07% 60
2025
Q1
$803K Buy
7,959
+1,411
+22% +$142K 0.07% 67
2024
Q4
$585K Buy
6,548
+425
+7% +$37.4K 0.05% 74
2024
Q3
$513K Buy
6,123
+186
+3% +$14.7K 0.05% 80
2024
Q2
$457K Buy
5,937
+353
+6% +$25.8K 0.04% 80
2024
Q1
$382K Buy
5,584
+443
+9% +$28.5K 0.04% 83
2023
Q4
$297K Buy
5,141
+426
+9% +$22.7K 0.03% 81
2023
Q3
$249K Buy
+4,715
New +$247K 0.03% 80

Other funds holding BSX

Hartford Funds Management's BSX Position: Q3 2025 in Review

Hartford Funds Management sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 8,060 shares — an estimated $866K sold.

Hartford Funds Management first reported a position in BSX in Q3 2023 and held it in 8 quarters. The position peaked at $866K in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Hartford Funds Management reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Hartford Funds Management sold 8,060 Boston Scientific shares in Q3 2025, an estimated $866K.
  • Hartford Funds Management first reported a position in Boston Scientific in Q3 2023 and held it in 8 quarters.
  • Hartford Funds Management's Boston Scientific position peaked at $866K in Q2 2025.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Hartford Funds Management's 13F filing for Q3 2025, filed 13 Nov 2025.